USPTO serial 77491669
Reviewed by CopyMark Law Group
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Cambridgeshire, GB
Cambridgeshire, GB
CAMBERLEY, SURREY
Cambridgeshire, GB
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
MARK HARRISON
MARK HARRISON VENABLE LLPP.O. Box 34385WASHINGTON, DC 20043-9998UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 001 | [ Chemical, biochemical and biological preparations and reagents, for investigating solids, liquids or gases, all for non-medical use; chemical reagents for non-medical use; chemicals preparations for use as reagents for investigating solids, liquids or gases for non-medical use; chemicals, reagents and chemical preparations for use in diagnostics, namely, diagnosing characteristics of solids, liquids or gases except for medical and veterinary use; chemicals, reagents and chemical preparations for use in tests and testing to investigate, analyze, characterize or monitor solids, liquids or gases except for medical and veterinary use; kits and assays comprised of chemicals, reagents and chemical preparations, for investigating, testing, analyzing, diagnosing or monitoring of solids, liquids or gases, all for non-medical use; chemical assays for research purposes; kits and assays comprised of chemicals and chemical preparations for testing soil samples ] | SECTION 8 - CANCELLED | — |
| 005 | Chemical, biochemical and biological preparations and reagents for medical [ and veterinary ] purposes, namely, for the diagnosis and characterization of infectious diseases, blood grouping, virology, [ genetics, oncology, hepatology, pharmacogenetics, cardiovascular diseases, respiratory ailments, ] serology, [ immunology, ] hematology, [ metabolic disease, neurological disease, gastrointestinal disease, dermatology, urology, obstetrics ] and gynecology; medical [ and veterinary ] testing preparations for investigation, testing, analysis, characterization or monitoring of biological material, namely, blood, plasma, serum, [ cells, saliva, ] urine, feces [, semen, cerebral spinal fluid, tissue and skin; ] reagents for medical [ and veterinary ] purposes; medical [ and veterinary ] preparations for the diagnosis of infectious diseases, blood grouping, virology, [ genetics, oncology, hepatology, pharmacogenetics, cardiovascular diseases, respiratory ailments, ] serology, [ immunology, ] hematology, [ metabolic disease, neurological disease, gastrointestinal disease, dermatology, urology, obstetrics ] and gynecology; medical [ and veterinary ] preparations for testing for and in the diagnosis and characterization of infectious diseases, blood grouping, virology, [ genetics, oncology, hepatology, pharmacogenetics, cardiovascular diseases, respiratory ailments, ] serology, [ immunology, ] hematology, [ metabolic disease, neurological disease, gastrointestinal disease, dermatology, urology, obstetrics ] and gynecology; kits and assays comprised of chemical reagents, [ sample collection devices, ] lateral flow test devices, [ microtitre plates, culture media, pipette stirrers, needles, ] dispenser bottles and test cards, for diagnosis and testing of blood, plasma, serum, [ cells, saliva, ] urine, feces, [ semen, cerebral spinal fluid, tissue and skin ] in the medical [ and veterinary ] fields | SECTION 8 - CANCELLED | — |
| 010 | [ Diagnostic, screening and testing apparatus and instruments for use in diagnosing, screening testing, analyzing and monitoring of biological material for medical and veterinary purposes; chemical, biochemical and biological detection apparatus and instruments for obtaining, sampling, analyzing and monitoring of biological material for medical and veterinary purposes; diagnostic and testing apparatus and instruments for use in diagnosing, testing, analyzing and monitoring of biological material for medical and veterinary purposes; automated sampling, testing and diagnostic apparatus and instruments for use in the medical and veterinary fields, namely, for testing for and diagnosis and characterization of infectious diseases, blood grouping, virology, genetics, oncology, hepatology, pharmacogenetics, cardiovascular diseases, respiratory ailments, serology, immunology, hematology, metabolic disease, neurological disease, gastrointestinal disease, dermatology, urology, obstetrics and gynecology, genetic diseases, bone disease and for orthodontics; kits for medical and veterinary testing purposes consisting of chemical reagents, sample collection devices, lateral flow test devices, microtitre plates, culture media, pipette stirrers, needles, dispenser bottles and test cards; medical and veterinary apparatus and instruments for diagnostic and testing purposes in relation to infectious diseases, blood grouping, virology, antibodies, genetics, oncology, hepatology, pharmacogenetics, cardiovascular diseases, and respiratory ailments ] | SECTION 8 - CANCELLED | — |
| 016 | [ Printed matter, namely, leaflets, brochures, paper labels, booklets, manuals, magazines, books, guides, pamphlets, catalogues, journals, newsletters, articles, reports, press releases, promotional literature and product guides, all relating to the medical and veterinary fields; packaging for products, namely, packaging made from paper, cardboard, and combinations thereof; packaging for products, namely, plastic bags, pouches, blister cards, and bubble packs; printed matter for use with diagnostic, screening, analyzing, chemical, biochemical and biological detection, monitoring and control apparatus and instruments, medical and veterinary apparatus and instruments, namely, leaflets, brochures, booklets, manuals, books, guides, pamphlets, catalogues, articles and reports; printed matter, namely, instructional leaflets and information sheets, brochures, and related promotional literature in the field of medical and veterinary apparatus ] | SECTION 8 - CANCELLED | — |
| 042 | [ Scientific research services; industrial research services in the field of diagnosis, screening, analysis and monitoring of solids, liquids, gases or biological material; biological, biochemical and chemistry research services; drug discovery services; clinical trial services; preclinical services, namely, investigation in the nature of characterization, optimization, profiling, efficacy, toxicity and therapeutic effect of drugs and diagnosis, analysis, testing and monitoring of biological and chemical material for the purpose of identification and characterization of medical and veterinary conditions, illnesses and diseases; clinical diagnostic services, namely, investigation in the nature of diagnosis, analysis, testing and monitoring of patients for the purpose of identification and characterization of patients before, during and after therapy or treatment; diagnostic, analytical, testing and monitoring services relating to pharmaceutical lead identification and optimization, drug resistance profiling and selection, and cellular and pharmaceutical toxicity; scientific research and medical consultancy services in the fields of preclinical and clinical trials; medical and veterinary research services ] | SECTION 8 - CANCELLED | — |
| 044 | [ Medical and veterinary consultancy services in the fields of diagnostic medical and veterinary testing; medical and veterinary services in the sampling, testing, screening and diagnosis of medical and veterinary conditions ] | SECTION 8 - CANCELLED | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 14, 2022 | CAEX | CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 | — |
| Jul 12, 2020 | REM2 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | — |
| Jul 3, 2019 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Jul 23, 2018 | NAS8 | NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED | — |
| Jul 23, 2018 | 8.PR | REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED | — |
| Jul 9, 2018 | EROP | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED | — |
| Jul 3, 2018 | EROP | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED | — |
| Jan 26, 2018 | PRA8 | POST REGISTRATION ACTION MAILED - SEC. 8 | — |
| Jan 25, 2018 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jan 10, 2018 | ES8R | TEAS SECTION 8 RECEIVED | — |
| Jan 10, 2017 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 12, 2011 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 26, 2011 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 6, 2011 | NPUB | NOTICE OF PUBLICATION | — |
| Mar 21, 2011 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Mar 14, 2011 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Mar 14, 2011 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 14, 2011 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 14, 2011 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 9, 2011 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Feb 28, 2011 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Feb 16, 2011 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Feb 14, 2011 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Feb 14, 2011 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 14, 2011 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Feb 14, 2011 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 13, 2011 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 13, 2011 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 12, 2011 | ALIE | ASSIGNED TO LIE | — |
| Jan 11, 2011 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Aug 26, 2010 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 26, 2010 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 28, 2010 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 28, 2010 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 28, 2010 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Jan 29, 2010 | CNSI | INQUIRY AS TO SUSPENSION MAILED | — |
| Jan 28, 2010 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Jan 14, 2010 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Jan 14, 2010 | ALIE | ASSIGNED TO LIE | — |
| Jul 14, 2009 | CNSL | LETTER OF SUSPENSION MAILED | — |
| Jul 14, 2009 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jun 18, 2009 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Jun 18, 2009 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 9, 2009 | PAPER RECEIVED | — | |
| Apr 17, 2009 | CNSL | LETTER OF SUSPENSION MAILED | — |
| Apr 16, 2009 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Mar 25, 2009 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 25, 2009 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 23, 2009 | ALIE | ASSIGNED TO LIE | — |
| Mar 20, 2009 | PAPER RECEIVED | — | |
| Sep 23, 2008 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 22, 2008 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 16, 2008 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 10, 2008 | MPMK | NOTICE OF PSEUDO MARK MAILED | — |
| Jun 9, 2008 | NWAP | NEW APPLICATION ENTERED | — |